Biomed professor featured in publication for drug delivery research

Feb 20, 2014 | Engineering and Science, Research and Development

800×600 Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:”Table Normal”; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:”Times New Roman”,”serif”;}

Dr. Mary Caldorera-Moore, assistant professor of biomedical engineering for Louisiana Tech University’s College of Engineering and Science, is being featured in “Design News” for her research in intelligent drug delivery.

Dr. Mary Caldorera-Moore

Dr. Mary Caldorera-Moore

The article mentions Caldorera-Moore’s research alongside that of Robert Langer, a professor at MIT and U.S. National Medal of Science winner, and Nicholas Peppas, professor and chair of biomedical engineering and director of the Center on Biomaterials, Drug Delivery, and Bionanotechnology at the University of Texas at Austin.  Both Langer and Peppas are internationally-recognized leaders in the field of drug delivery.  The article states that all three researchers “are taking a chemistry-oriented approach to intelligent drug delivery.”

Design News is a print and online resource that provides a channel for two-way communications amongst the engineering community with content normally in the form of design application articles, blogs, product teardowns and webinars. 

In the article, Caldorera-Moore discusses the advantages of intelligent drug delivery that targets an affected area of the body and administers only the needed dosage for treatment of cancer and other diseases.  Caldorera-Moore says drugs that are administered intravenously expose the entire body to the drug.  In the case of chemotherapy, this effect can be quite harsh, but by creating drugs that are pH-, temperature-, and biomolecule-responsive, clinicians will be able to use less treatment, which will lessen patient side effects and drive down the cost.

“It is exciting to see Dr. Caldorera-Moore’s research in intelligent drug delivery recognized along with such highly regarded leaders as Drs. Langer and Peppas,” says Dr. Hisham Hegab, interim dean of the College of Engineering and Science at Louisiana Tech. “Her work is an excellent example of the impact that investment in highly qualified faculty members and research infrastructure can have for higher education in our state.”

As a graduate student at the University of Texas at Austin, Caldorera-Moore conducted research with Georgia Tech Professor Krishnendu Roya.  She went on to receive her doctorate in biomedical engineering from UT-Austin in 2010 and continued her postdoctoral research with Peppas before joining the faculty at Louisiana Tech to run its Therapeutic Micro- and Nanotechnology Biomaterial Laboratory. Written by Catherine Fraser –